Global Bio-chem Technology Group Company Limited
Symboli: 0809.HK
HKSE
0.102
HKDMarkkinahinta tänään
0.2024
P/E-suhde
0.0037
PEG-suhde
908.56M
MRK Cap
- 0.00%
DIV Tuotto
Global Bio-chem Technology Group Company Limited (0809-HK) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 88.4 | 41.8 | 21.8 | ||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 227.3 | 53.9 | 87.3 | ||||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 395.9 | 279.3 | 443.1 | ||||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 148.3 | 216.7 | 81.4 | ||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 336.9 | 149.6 | 45.4 | ||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 969.5 | 687.6 | 592.2 | ||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 4220.2 | 5158.4 | 5886.5 | ||||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 2 | 3.8 | 3.8 | ||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 2 | 3.8 | 3.8 | ||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 17.3 | 0.2 | 0.2 | ||||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | -0.2 | -0.2 | ||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0.2 | 0.2 | ||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 4239.6 | 5162.3 | 5890.5 | ||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 5209.1 | 5849.9 | 6482.7 | ||||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 904.2 | 1201.5 | 1172.2 | ||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 4637.7 | 8152.9 | 7503.2 | ||||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 103.5 | 331.4 | 319.7 | ||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 811.8 | 0.3 | 941.1 | ||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 31.3 | 100.8 | 115.2 | ||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 2697.7 | 4032.4 | 3268.1 | ||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 850.4 | 130.9 | 1147.9 | ||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0.3 | 2.2 | 4.1 | ||||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 9246 | 13636.9 | 13183.5 | ||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 11279 | 10257.7 | ||||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 890.7 | 890.7 | 890.7 | ||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -9832.2 | -15203.9 | -13760.8 | ||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 2055.2 | 3924.9 | 3503.1 | ||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2849.3 | -8429.7 | -7408.4 | ||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | -4036.9 | -7539 | -6517.7 | ||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 5209.1 | 5849.9 | 6482.7 | ||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | -248.1 | -183.1 | ||||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | -4036.9 | -7787.1 | -6700.8 | ||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||||||||
Total Investments | 0 | 17.3 | 0.2 | 0.2 | ||||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 5449.5 | 8153.2 | 8444.3 | ||||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 5361.2 | 8111.5 | 8422.5 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -1573.8 | -409.5 | -2410.9 | |||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 330.5 | 402.5 | 456.9 | |||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 413.9 | 38.1 | 566.3 | |||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | 47 | 21.3 | 119.2 | |||||||||||||||||||||||
cash-flows.row.inventory | 0 | -142.1 | 36.1 | 243.4 | |||||||||||||||||||||||
cash-flows.row.account-payables | 0 | 114.1 | -216.3 | -286 | |||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 394.9 | 197 | 489.7 | |||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 741.4 | -506.4 | 1361.5 | |||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -6.2 | -25.8 | -16.8 | |||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 5.8 | 418.4 | 0 | |||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 136.9 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -0.4 | 392.6 | 120.1 | |||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -68.9 | -404.3 | -365 | |||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 132.7 | |||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 178.7 | 355.6 | 206.4 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 109.8 | -48.7 | -25.9 | |||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -1.4 | -0.2 | 5.8 | |||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 20 | -131.5 | 73.8 | |||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 41.8 | 21.8 | 153.3 | |||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 21.8 | 153.3 | 79.5 | |||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -88 | -475.2 | -26.2 | |||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -6.2 | -25.8 | -16.8 | |||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -94.2 | -501 | -43 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1373.9 | 372.3 | 746.6 | ||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1330.3 | 337.7 | 698.2 | ||||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 43.6 | 34.6 | 48.4 | ||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -237.7 | -1 | -5.3 | ||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 361.8 | 366.9 | 430.9 | ||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1692.1 | 704.5 | 1129.1 | ||||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0.3 | ||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 750.4 | 726.2 | 790.6 | ||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 4019.2 | -724.4 | 564.4 | ||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -237.7 | -1 | -5.3 | ||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 4019.2 | -724.4 | 564.4 | ||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 750.4 | 726.2 | 790.6 | ||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 241.8 | 330.5 | 402.5 | ||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | -318.2 | -849.4 | -973.8 | ||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 3701 | -1573.8 | -409.5 | ||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -42.1 | -54.2 | 25.9 | ||||||||||||||||||||||||
income-statement-row.row.net-income | 0 | 4224.6 | -1519.6 | -435.4 |
Usein kysytty kysymys
Mikä on Global Bio-chem Technology Group Company Limited (0809.HK) taseen loppusumma?
Global Bio-chem Technology Group Company Limited (0809.HK) kokonaisvarat ovat 5209096000.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on N/A.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.032.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on -0.017.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on 3.075.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on -0.238.
Mikä on Global Bio-chem Technology Group Company Limited (0809.HK) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on 4224593000.000.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 5449538000.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 361805000.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 0.000.